Ring20 Research & Support UK CIO’s Post

#Epilepsy is the most common and potentially devastating neurological disease that affects people across the lifespan. Help us attract the brightest scientists and clinicians to the field to improve outcomes for people with epilepsy. Make a difference by making a gift today: #EpilepsyDay #InternationalEpilepsyDay

🚨 New funding announcement alert! 🚨 BD² Discoveries is announcing $9.2m available for four new clinical sites to join the BD2 Integrated Network to accelerate research and care for #bipolardisorder. More information is below! #bipolardisorder #newfunding #philanthropy #researchfunding

The epilepsy community needs your help! The AMERICAN BRAIN COALITION has created an opportunity for you to write your representatives at this critical time to ask them to sign on to support increased funding for the NIH BRAIN Initiative, and to support increases for the National Institute of Neurological Disorders and Stroke (NINDS). Use the link to be taken to a page where you can find your legislator and to a template draft letter that you may edit and send. You can add to this template and ask for NINDS support. Suggested copy to include in your message: "I also ask your support for increased funding for the National Institute of Neurological Disorders and Stroke (NINDS). Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. The impact of conditions like epilepsy, stroke, headache, and neurodegenerative diseases will continue to grow as the population ages. It is vital to increase support for research to sustain recent advances in treating previously untreatable conditions, to relieve the burden of suffering they cause, and to reduce the economic burden to the nation in care and years of productive and fulfilling lives lost." https://lnkd.in/gygv2HZU

Travel time to academic settings can contribute to inequalities due to age, geography, and ethnicity in Alzheimer's disease clinical trial enrollment. We are excited to share that Noor Sachdev M.D. and Perminder Bhatia, M.D., two community physicians in the Adaptive Research network, are investigators in AriBio’s Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (POLARIS-AD). #clinicaltrials #clinicalresearch

Vivli Researcher Spotlight: 🔦 Check out our newest update, with researcher Dr. Sarah Nevitt, on using Vivli to access #clinicaltrialdata, and possibilities for achieving better control and remission of seizures in people with epilepsy: https://lnkd.in/eSUrwsdQ

🧠💡 It’s Multiple Sclerosis (MS) Awareness Week! MS is a disease that affects the brain, spinal cord, and optic nerves, causing physical and cognitive disabilities. Myelin-H is very pleased to share that we are on the cusp of commencing an international & multi-site clinical trial on remote monitoring and neurorehabilitation of Multiple Sclerosis. With a myriad of portrayed stories of devastating daily experiences around three million patients are going through, we cannot afford to miss this opportunity to empower those people affected by MS with groundbreaking neurotechnology to live their best lives. We will soon be recruiting for the clinical trial. We invite you to get in touch (https://lnkd.in/eG4zwFYj) and participate in the clinical Study – a groundbreaking medical device clinical trial for our first non-invasive brain-machine interface for remote MS monitoring and neurorehabilitation. If you or a loved one has been impacted by MS, we want to hear from you. Your stories inspire us and drive our mission forward.  Together, let’s turn awareness into action and pave the way for a brighter future for those living with MS. #MSAwareness #Neurotechnology #MyelinH #ClinicalTrial #Empowerment #braincomputerinterface #digitalhealth #brainhealth #neurotechnology

Epilepsy is a neurological disorder impacting millions worldwide. More than just seizures, it's a spectrum of disorders that affects individuals and families, altering daily lives. Awareness and understanding can help dispel myths and foster a more inclusive society. At HiRO, we stand in solidarity with every individual living with epilepsy. Our commitment to pioneering biotech solutions reinforces our belief in a brighter, seizure-free future. 🔬 With each research initiative and collaboration, we inch closer to making this vision a reality. Join HiRO this November in raising awareness, reducing stigma, and championing advancements in epilepsy research and treatment. 🎗️ Support the cause and make a difference. Use #EpilepsyAwareness to share and amplify the message.

Sponsored by German #NPBI NRW.BANK, the ichó therapy ball is a device for promoting cognition and motor skills in patients with dementia, stroke, Parkinson's disease and even children with autism, Down syndrome or severe multiple disabilities. The Therapy Ball uses the principle of neuroplasticity to playfully promote the patient's abilities with more than 100 available ichó apps to build everyday skills and improve quality of life. At the same time, the therapy system collects patient data, which enables physicians and therapists to adapt the therapies individually to the patient's needs. With the help of this real word data, a previous black box in healthcare opens up and shows the patient's condition in the real world, outside the doctor's office. Read more about further projects, sponsored by European NPBIs, in the ELTI Brochure on #Innovation here: https://lnkd.in/eJyMDyGi

Join the CND Life Sciences team at Lisbon to learn about their progressive work in #neurodegenerativediseases. #pathology #digitalpathology

Some more #sundayscience, reclassifying #parkinsonsdisease via University Health Network #research. #researchmatters #sciencematters #newmedsmatter #parkinsons #parkinsonsawareness https://lnkd.in/eaSRj-_4